93 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34979464 | Design, synthesis and SAR study of Fluorine-containing 3rd-generation taxoids. | 2022 Feb | 1 |
2 | 35173861 | Apatinib inhibits paclitaxel resistance of gastric carcinoma cells through VEGFR2 pathway. | 2022 | 1 |
3 | 35623257 | Laser-responsive multi-functional nanoparticles for efficient combinational chemo-photodynamic therapy against breast cancer. | 2022 Aug | 2 |
4 | 33049093 | Esomeprazole overcomes paclitaxel-resistance and enhances anticancer effects of paclitaxel by inducing autophagy in A549/Taxol cells. | 2021 Jan | 1 |
5 | 33513992 | Hyaluronic Acid-Targeted Stimuli-Sensitive Nanomicelles Co-Encapsulating Paclitaxel and Ritonavir to Overcome Multi-Drug Resistance in Metastatic Breast Cancer and Triple-Negative Breast Cancer Cells. | 2021 Jan 27 | 1 |
6 | 33691261 | Therapeutic strategies to overcome taxane resistance in cancer. | 2021 Mar | 1 |
7 | 33758505 | Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis. | 2021 | 1 |
8 | 33804018 | Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs. | 2021 Mar 15 | 1 |
9 | 34413359 | Structure activity relationships and the binding mode of quinolinone-pyrimidine hybrids as reversal agents of multidrug resistance mediated by P-gp. | 2021 Aug 19 | 1 |
10 | 31783010 | Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin. | 2020 Jan | 1 |
11 | 32897218 | [Long-chain non-coding RNA MALAT1 regulates paclitaxel resistance of breast cancer cells by targeting miR-485-3p]. | 2020 May 30 | 2 |
12 | 30292104 | Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells. | 2019 Feb 1 | 1 |
13 | 30367323 | Chemotherapy in pregnancy: exploratory study of the effects of paclitaxel on the expression of placental drug transporters. | 2019 Oct | 3 |
14 | 30431082 | ERp57‑small interfering RNA silencing can enhance the sensitivity of drug‑resistant human ovarian cancer cells to paclitaxel. | 2019 Jan | 1 |
15 | 30530177 | Basic principles of drug delivery systems - the case of paclitaxel. | 2019 Jan | 1 |
16 | 30540465 | Probing the Pharmacological Binding Sites of P-Glycoprotein Using Umbrella Sampling Simulations. | 2019 May 28 | 1 |
17 | 30556139 | Effect of endogenous multidrug resistance 1 and P-glycoprotein expression on anticancer drug resistance in colon cancer cell lines. | 2019 Jan | 2 |
18 | 30600025 | Self-assembled micelles based on N-octyl-N'-phthalyl-O-phosphoryl chitosan derivative as an effective oral carrier of paclitaxel. | 2019 Mar 1 | 2 |
19 | 30959904 | Cytotoxic Effect of Paclitaxel and Lapatinib Co-Delivered in Polylactide-co-Poly(ethylene glycol) Micelles on HER-2-Negative Breast Cancer Cells. | 2019 Apr 6 | 1 |
20 | 31536779 | In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆. | 2019 Dec 1 | 1 |
21 | 31875434 | [Role of protein kinase D1 in regulating the growth, apoptosis and drug sensitivity of oral squamous carcinoma cells]. | 2019 Dec 1 | 1 |
22 | 29253998 | N-mercapto acetyl-N'-octyl-O, N″-glycol chitosan as an efficiency oral delivery system of paclitaxel. | 2018 Feb 1 | 1 |
23 | 29439899 | High expression of class III β-tubulin has no impact on functional cancer cell growth inhibition of a series of key vinblastine analogs. | 2018 Mar 1 | 2 |
24 | 29683800 | Generation and characterization of a paclitaxel-resistant human gastric carcinoma cell line. | 2018 Jul | 2 |
25 | 30251669 | Nitric oxide reverses drug resistance by inhibiting ATPase activity of p-glycoprotein in human multi-drug resistant cancer cells. | 2018 Dec | 1 |
26 | 30308274 | Self-assembly of biotinylated poly(ethylene glycol)-poly(curcumin) for paclitaxel delivery. | 2018 Dec 20 | 1 |
27 | 30444601 | Hydrogen-Bonded Tannic Acid-Based Anticancer Nanoparticle for Enhancement of Oral Chemotherapy. | 2018 Dec 12 | 1 |
28 | 27750197 | Extending the structure-activity relationship study of marine natural ningalin B analogues as P-glycoprotein inhibitors. | 2017 Jan 5 | 1 |
29 | 28253574 | [Reverse of the resistance to paclitaxel of the heparin binding-epidermal growth factor-like growth factor inhibitor in ovarian cancer]. | 2017 Feb 25 | 4 |
30 | 28441715 | Targeting the Bcl-2 family and P-glycoprotein reverses paclitaxel resistance in human esophageal carcinoma cell line. | 2017 Jun | 3 |
31 | 26820614 | Human-Mouse Chimeras with Normal Expression and Function Reveal That Major Domain Swapping Is Tolerated by P-Glycoprotein (ABCB1). | 2016 Feb 23 | 2 |
32 | 26900771 | Cell-Penetrating, Guanidinium-Rich Oligophosphoesters: Effective and Versatile Molecular Transporters for Drug and Probe Delivery. | 2016 Mar 16 | 2 |
33 | 27262378 | Ferulic acid reverses ABCB1-mediated paclitaxel resistance in MDR cell lines. | 2016 Sep 5 | 1 |
34 | 27301180 | The Effect of Surfactant on Paclitaxel Nanocrystals: An In Vitro and In Vivo Study. | 2016 Jan | 1 |
35 | 27304668 | Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways. | 2016 Jul 5 | 1 |
36 | 27664577 | Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters. | 2016 Nov 1 | 1 |
37 | 27763524 | Characterization, in Vivo and in Vitro Evaluation of Solid Dispersion of Curcumin Containing d-α-Tocopheryl Polyethylene Glycol 1000 Succinate and Mannitol. | 2016 Oct 17 | 2 |
38 | 27863655 | Direct in vivo evidence on the mechanism by which nanoparticles facilitate the absorption of a water insoluble, P-gp substrate. | 2016 Nov 30 | 1 |
39 | 25677062 | NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo. | 2015 Apr | 2 |
40 | 25904021 | Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis. | 2015 Oct 15 | 1 |
41 | 26076081 | IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance. | 2015 Aug 19 | 1 |
42 | 26144859 | Novel dietary lipid-based self-nanoemulsifying drug delivery systems of paclitaxel with p-gp inhibitor: implications on cytotoxicity and biopharmaceutical performance. | 2015 | 1 |
43 | 26233798 | Optimization of permethyl ningalin B analogs as P-glycoprotein inhibitors. | 2015 Sep 1 | 1 |
44 | 26265061 | Investigating the role of Pluronic-g-Cationic polyelectrolyte as functional stabilizer for nanocrystals: Impact on Paclitaxel oral bioavailability and tumor growth. | 2015 Oct | 2 |
45 | 26514453 | Enhancing Activity of Anticancer Drugs in Multidrug Resistant Tumors by Modulating P-Glycoprotein through Dietary Nutraceuticals. | 2015 | 1 |
46 | 26536707 | [The effect of MDR1 (P-gp) and ABCG2 on the drug resistance in Hep 2 cells]. | 2015 Jun | 2 |
47 | 24239580 | Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform. | 2014 Jan 2 | 1 |
48 | 24805866 | Role and mechanism of Twist1 in modulating the chemosensitivity of FaDu cells. | 2014 Jul | 1 |
49 | 24866272 | A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer. | 2014 Aug 25 | 1 |
50 | 24927684 | Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel. | 2014 Aug | 1 |